Be the first person to write a business review for Cardinal Health Medical

CardioNet, Inc. provides ambulatory, continuous, and real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health in the United States. It focuses on diagnosing and monitoring cardiac arrhythmias or heart rhythm disorders. The company offers Mobile Cardiac Outpatient Telemetry (MCOT) device that incorporates a patient-worn sensor attached to leads, which captures electrocardiogram (ECG) data and communicates wirelessly with a compact monitor that analyzes incoming information by applying proprietary algorithms designed to detect arrhythmias and eliminate data noise. Its MCOT device automatically transmits the ECG data to the CardioNet Monitoring Center, when the monitor detects an arrhythmic event. CardioNet also provides event monitoring services to record and store approximately 540 seconds of ECG signal; Holter monitoring services that store an image of the electrical impulses of every heartbeat or irregularity in either digital format on an internal compact flashcard or in analog format on a standard cassette tape located inside the monitor. In addition, it offers pacemaker monitoring services. CardioNet, Inc. markets its arrhythmia monitoring solutions, including the MCOT, primarily to cardiologists and electrophysiologists. CardioNet, Inc. has a strategic alliance with MedApps, Inc. CardioNet, Inc. was incorporated in 1994 and is headquartered in Conshohocken, Pennsylvania.

CareFusion Corporation, a medical technology company, provides various healthcare products and services in the United States and internationally. It operates in two segments, Critical Care Technologies, and Medical Technologies and Services. The Critical Care Technologies segment develops, manufactures, and markets equipment and related supplies for infusion, medication and supply dispensing, and respiratory care products. Its products include intravenous medication safety and infusion therapy delivery systems comprising disposables, software applications, and related patient monitoring equipment; automated dispensing machines and related applications for distributing and managing medication and medical supplies; and equipment and supplies for ventilation, and respiratory and sleep diagnostics. The Medical Technologies and Services segment develops, manufactures, and markets disposable infection prevention products, software-based infection detection services, surgical and diagnostic instrumentation, and neurological monitoring equipment. It offers skin disinfectant and other patient-preparation products, hair-removal and skin-care products, infection detection software, and custom surgical procedure kits; surgical instruments and related products and services, and interventional specialty products, such as diagnostic trays and biopsy needles, drainage catheters and vertebral augmentation products, and neurological monitoring and diagnostic products. CareFusion Corporation serves hospitals and other healthcare facilities comprising oncology clinics, ambulatory surgical centers, clinics, long-term care facilities, and physician offices. CareFusion Corporation sells its products and services through a combination of direct sales representatives and third-party distributors. CareFusion Corporation is headquartered in San Diego, California.

CAS Medical Systems, Inc. develops and manufactures medical devices for non-invasive patient monitoring. The company’s FORE-SIGHT Absolute Cerebral Oximeter is a cerebral oximeter available with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for all patients, regardless of age or weight. This information helps avert brain damage or death during surgery and in critical care situations by allowing clinicians to identify patients with dangerously low levels of cerebral oxygen and intervene to reverse the condition. CAS Medical Systems’ product lines include the high-acuity monitoring capabilities of the FORE-SIGHT Cerebral Oximeter; and MAXNIBP, a proprietary non-invasive blood pressure measurement technology. The company also offers a line of bedside vital signs monitoring products, and supplies and service, including blood pressure cuffs and products for neonatal intensive care. CAS Medical Systems markets its products through its own sales force, distributors, and manufacturers representatives, as well as through hospital, alternate site, homecare, veterinary, and emergency medical distribution channels. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut.

CCS Medical Holdings, Inc. emerged from Chapter 11 bankruptcy protection in 2010. CCS Medical Holdings knows that doorstep delivery is just a convenience for many, but it's critical for patients with chronic conditions. The company provides mail-order delivery of medical supplies to treat diabetes, as well as chronic wounds, incontinence, respiratory ailments, and other illnesses. CCS distributes a variety of drugs and medical supplies including blood glucose meters, catheters, insulin pumps, nebulizers, and ostomy and wound care supplies. It is one of the largest providers of respiratory medications and diabetes testing supplies to Medicare customers.

China Medical Technologies, Inc. (the "Company") is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products using Enhanced Chemiluminescence ("ECLIA") technology, Fluorescent in situ Hybridization ("FISH") technology and Surface Plasmon Resonance (“SPR”) technology to detect and monitor various diseases and disorders. China Medical Technologies was listed on the Nasdaq Global Select Market on August 10, 2005 and trades under the ticker "CMED". ECLIA is operated through our wholly-owned subsidiary Beijing Yuande Bio-Medical Engineering Co., Ltd. ("Yuande") in China. Yuande was established in 1999 and its headquarters and manufacturing facilities are located in the Beijing Economic-Technological Development Area. The Company was awarded ISO 9001 certification and ISO 13485:2003 certification in 2006.Our first ECLIA analyzers and reagents were launched in 2004. In light of the Company's extensive research in chemiluminescence technology, we believe we are one of the first China-based companies to successfully develop the products and, more importantly, the first to offer an integrated platform including self-developed analyzers and reagents. We manufacture both the equipment and reagents that detect and monitor various diseases and disorders by analyzing blood through laboratory evaluation. FISH and SPR are operated through our other wholly-owned subsidiary, Beijing GP Medical Technologies, Ltd., which was established in 2006. We acquired our FISH business in March 2007 and launched our FISH-related products in the same year. We believe the FISH products will complement our existing ECLIA diagnostic products by providing proprietary tests for the diagnosis of prenatal and postnatal disorders as well as various cancers that arise from genetic mutations.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.